RVT-101 35 mg

DRUG3 trials

Sponsors

Axovant Sciences Ltd.

Conditions

Alzheimer's DiseaseDementia With Lewy BodiesParkinson's Disease Dementia

Phase 2

Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study

CompletedNCT02669433

Axovant Sciences Ltd.Dementia With Lewy Bodies

Start: 2016-01-31End: 2017-12-31Updated: 2019-04-26

Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia

CompletedNCT02910102

Axovant Sciences Ltd.Alzheimer's Disease, Dementia With Lewy Bodies, Parkinson's Disease Dementia

Start: 2016-10-31End: 2017-11-30Updated: 2020-04-28

Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension

TerminatedNCT02928445

Axovant Sciences Ltd.Dementia With Lewy Bodies

Start: 2016-10-31End: 2018-02-28Target: 240Updated: 2018-04-18